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Ligands of NGF and GDNF families of neurotrophic factors have important functions in the development
of the vertebrate peripheral nervous system (PNS). It has been established that they also play key roles in
the regeneration of PNS. Expression patterns of NGF and GDNF family members and their receptors have7 November 2009
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DNF family of neurotrophic factors
mostly been analyzed during regeneration, and less during development of the PNS. We describe the
expression of mRNAs encoding these neurotrophic factors and their receptors during development of rat
sciatic nerve and in three modes of differentiation of cultured rat Schwann cells. Our results demonstrate
speciﬁc expression patterns of NGF and GDNF family ligands and their receptors during differentiation
of Schwann cells in vivo and in vitro.
. ciatic nerve
chwann cell
. Introduction
Members of both NGF and GDNF families of neurotrophic fac-
ors are important in the development of the vertebrate PNS [3,2].
eurotrophins BDNF and NGF are important positive regulators of
yelination by Schwann cells, whereas NT-3 negatively regulates
yelination in PNS. Exogenous administration of BDNF enhances
yelination in PNS, whereas removal of endogenous BDNF inhibits
yelination in mice [6,26]. Positive effect of BDNF on myelination
n PNS comes through binding of BDNF to p75NTR receptor [8]. In
ddition, BDNF is required for re-myelination in the injured periph-
ral nerve in rodents in vivo [29]. It has been suggested that the
ajor source of BDNF supportingmyelination inDRG and Schwann
ell co-cultures is neuronal cells [22]. NGF promotes myelination
n DRG and Schwann cell co-cultures, whereas blocking NGF activ-
ty in vivo inhibits myelination [7]. GDNF promotes myelination of
mall caliber axons that normally do not myelinate and enhances
yelination in neuron-Schwann cell co-cultures [12,14]. In con-
rast, NT-3 negatively regulates myelination in vivo and this effect
s achieved through binding of NT-3 to its high afﬁnity receptor
TRK3 [6].
Schwann cells are the major macroglial cells in PNS. Theynsheath axons and, depending on axon caliber, differentiate
o either myelinating or non-myelinating Schwann cells. Upon
eripheral nerve injury they de-differentiate, start to proliferate,
upport regeneration of the peripheral nerve and re-differentiate
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upon axonal regeneration (reviewed in Ref. [15]). Expression of
NGF and GDNF family members is regulated in the injured nerve
with speciﬁc time course for each gene [18,11,27]. In cell culture
rat Schwann cells proliferate in the presence of neuregulin and
low concentrations of forskolin. Upon elevated forskolin levels,
Schwann cells differentiate and induce the expression of myelin
genes [21]. GDNF and BDNF are the predominant neuregulin-
releasing neurotrophic factors produced by cultured Schwann cells
[9].
Despite the fact that neurotrophic factors have important roles
in PNS development, expression patterns of the factors during
nerve development has not been studied thoroughly. In the present
study we have analyzed the expression of NGF and GDNF family
members and their receptors during rat sciatic nerve develop-
ment and in three differentiation stages of cultured rat Schwann
cells.
2. Materials and methods
Rat Schwann cell (SC) cultures from postnatal day 3 rat pups
were established as described [5]. Pure SC culture was main-
tained and passaged in DMEM, 3% FCS, 2M forskolin and 5%
neuregulin-beta conditioned medium in Primaria (Clontech) tissue
culture dishes. In the differentiation experiments the medium was
replacedwith deﬁnedmedium (DMEM/F12, 1×N2 supplement and
Open access under CC BY license5%neuregulin-beta conditionedmedium) and incubatedovernight.
Next day the medium was replaced with deﬁned medium con-
taining 20M forskolin (Sigma) to induce the differentiation of
Schwann cells. The growth-arrested Schwann cells were grown in
deﬁned medium containing 0.2% DMSO to match the DMSO con-
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iig. 1. Quantitative RT-PCR analysis of expression of Schwann cell markers Oct-6,
BP and MAG mRNAs in proliferating (pSC), growth-arrested (gaSC) and differen-
iated (dSC) Schwann cells. Expression levels are represented relative to the level of
he respective mRNA in pSC, which was arbitrarily set at one.
entration in the culture media of differentiated cells, treated with
orskolin dissolved in DMSO. Thirty-six hours later the cells were
sed for subsequent analysis. Cell cycle proﬁles were measured by
ropidium iodide staining and BrdU incorporation using cell sorter
acsCalibur (Becton Dickinson) [24].
Total RNA from rat tissues and Schwann cells was extracted
sing RNAWiz (Ambion). First-strand cDNAs were synthesized
ith Superscript III (Invitrogen) reverse transcriptase. PCR reac-
ions were performed using 1/50 of the ﬁrst-strand cDNA reaction
nd the PCR products were analyzed in the exponential phase of
mpliﬁcation. Primers used are depicted in Supplementary Table
. Real-time quantitative PCR (qPCR) analysis was performed in
riplicates using qPCR Core Kit for SYBR Green I (Eurogentec) with
ightcycler 2.0 (Roche) (Supplementary Table 2). Schwann cell
ata was normalized with housekeeping gene HPRT. Data was
nalyzed and standard deviation (SD) calculated as described [4].
xon-speciﬁc BDNF primers have been previously described [1].
DNF protein levels were measured in cell homogenates using
hemiKine Brain Derived Neurotrophic Factor Sandwich Elisa Kit
Chemicon).
. Results and discussion
.1. Expression of neurotrophins and their receptors during rat
eripheral nerve development and in cultured Schwann cells
In cultured Schwann cells neurotrophin expression was
nalyzed in cells growing under three different conditions. Prolif-
rating and growth-arrested Schwann cells expressed low levels
f differentiation marker Oct-6 and myelin genes MBP and MAG.
xpression of Schwann cell differentiation marker Oct-6 and
yelin genes MBP and MAG mRNAs was induced in differenti-
ted cells (Fig. 1). Proliferating Schwann cells exhibited normal
ell cycle proﬁle with 53.4% of the cells in G1, 30.3% in S and
5.5% in G2/M phase of the cell cycle as measured by propidium
odide staining and BrdU incorporation. Growth-arrested and dif-
erentiated Schwann cells did not proliferate with 87.4 and 88.2%
f the cells arrested in G1 phase of the cell cycle respectively
Supplementary Fig. 1). NGF mRNA was expressed during all three
odes of Schwann cell differentiation at 50-fold higher levels thann adult rat brain. BDNF mRNA was expressed at 35- and 20-fold
igher level in growth-arrested Schwann cells than in proliferating
nd differentiated cells respectively (Fig. 2A). The 35-fold induc-
ion of BDNF mRNA levels were accompanied by a 3-fold increase
n BDNF protein levels in growth-arrested cells as compared totters 469 (2010) 135–140
proliferating and differentiated cells (Fig. 2B). We did not detect
NT-3 and NT-4 expression in cultured Schwann cells (data not
shown).
We analyzed NGF, BDNF, NT-3 and NT-4 mRNA expression dur-
ing rat sciatic nerve development at embryonic day (E) 17, E19,
postnatal day (P) 3, P10, P20 and P60 by qPCR analysis. In general,
NGF, BDNF and NT-3 expression levels were higher in embry-
onic sciatic nerves and downregulated upon nerve development.
Expression levels of NGF, BDNF and NT-3 mRNAs were highest at
E17, the earliest developmental stage analyzed, decreased slightly
at E19 and were markedly downregulated during postnatal nerve
development (Fig. 2A). We could not detect NT-4 mRNA expression
in rat sciatic nerves (data not shown).
Expression of neurotrophins in the postnatal rodent sciatic
nerve has been shown previously [18,11]. Our results demon-
strating that neurotrophin expression is high in embryonic sciatic
nerves and the levels are decreasing during development suggests
two possible scenarios. First, it is possible that Schwann cells in the
embryonic nerves are not a homogenous population of glial cells,
but rather the phenotype of a Schwann cell depends on the type
of axon it is contacting with. This means that during late embryo-
genesis different Schwann cell populations express different set
of neurotrophins. This has also been suggested by a study showing
that Schwann cells in the regenerating peripheral nerve exhibit dis-
tinct sensory andmotorphenotypes [13]. Alternatively it is possible
that embryonic Schwann cells exhibit homogenous phenotype, but
express higher level of neurotrophins to provide maximal support
for growing axons.
Structure of BDNF gene is complex as compared to other neu-
rotrophins. Rat BDNF gene contains nine 5′ noncoding exons and
one coding exon. Each noncoding exon has its own promoter and
is differentially expressed in the nervous system and in other tis-
sues. The 5′ noncoding exons fall into two clusters, with exons I–III
as a 5′ cluster and exons IV–VIII 3′ cluster. In addition, a separate
promoter is driving expression of exon IXa transcripts initiating
in the 5′ region of exon IX [1]. Semiquantitative RT-PCR analysis
showed that BDNF exons II, IV, VI–IXa mRNAs were expressed in
sciatic nerve, with highest levels at E17, the ﬁrst developmental
stage analyzed (Fig. 2C) similarly to the levels of total BDNF mRNA
(Fig. 2A). In the adult sciatic nerve the expression of exons II and IV
mRNAswas induced indicating that the slight upregulationof BDNF
mRNA expression there could be accounted to the expression from
BDNF promoters II and IV (Fig. 2C).
In cultured Schwann cells BDNF exons I, III, IV, VI–IXa mRNAs
were expressed and the levels were highest in growth-arrested
Schwann cells similarly to total BDNF mRNA (Fig. 2C). Exon VIII
mRNA was expressed at lower level in proliferating Schwann
cells and at higher level in growth-arrested and differentiated
Schwanncell suggesting that the slight increase in the expressionof
BDNF in differentiated as compared to proliferating Schwann cells
observed in real-time PCR analysis could be attributed to exon VIII
expression. The fact that we detected BDNF exon II expression in
developing sciatic nerve but not in cultured Schwann cells suggests
that BDNF exon II is expressed in ﬁbroblasts or microglial cells of
the developing sciatic nerve. Alternatively, exon II transcripts are
expressed in Schwann cells in vivo but not in vitro. Our analysis also
showed that BDNF exon III was expressed only in growth-arrested
Schwann cells but not in the sciatic nerve suggesting that cell cul-
ture conditionsweusedpromoted ectopic expressionof BDNFexon
III in Schwann cells.
Next we investigated expression of receptors of neurotrophins
during sciatic nerve development. Expression of Ntrk1 (TrkA)
mRNA, coding thehigh afﬁnity receptor forNGF,washighest at E17,
decreased more than 5-fold at E19 and was almost undetectable
postnatally (Fig. 2D). Previous reports have found that Ntrk1 is
not expressed in the developing or regenerating rat sciatic nerve
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Fig. 2. (A) Quantitative RT-PCR analysis of expression of neurotrophin mRNAs during rat sciatic nerve development and in three modes of Schwann cell differentiation. (B)
Analysis of BDNF protein levels in three modes of Schwann cell differentiation using ELISA. (C) Semiquantitative RT-PCR analysis of expression of BDNF 5′ exon-speciﬁc
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RNAs during rat sciatic nerve development and in three modes of Schwann cell
RNA at E17 (in sciatic nerve development) or in pSC (in Schwann cells), which wa
ells, dSC: differentiated Schwann cells, BR: adult rat brain.
11,23]. It is possible that sensitivity of analyses did not allow the
etection of Ntrk1 expression in these studies. Ntrk2 (TrkB), the
igh afﬁnity receptor for BDNF and NT-4 has three major isoforms
16,19]. Full-length kinase domain containing Ntrk2FL is mainly
xpressed in neuronal cells, whereas kinase deﬁcient T1 and T2 iso-
orms are expressed in glial cells [10]. Ntrk2FL mRNA levels were
ighest in E17 sciatic nerve, 70-fold decreased at E19, undetectablentiation. (D) Quantitative RT-PCR analysis of expression of neurotrophin receptor
entiation. Expression levels are represented relative to the level of the respective
rarily set at one. pSC: proliferating Schwann cells, gaSC: growth-arrested Schwann
during early postnatal stages and upregulated during later devel-
opment (Fig. 2D). Ntrk2T1 mRNA level was highest at E17, and
decreased thereafter reaching 2-fold lower levels in adult sciatic
nerve (Fig. 2D). We did not detect Ntrk2T2 expression in the sciatic
nerve (data not shown). Our results are consistent with previously
published data about postnatal expression of NtrkT1 and lack of
Ntrk2T2 protein expression in the sciatic nerve [8]. It has also been
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Fig. 3. (A) Quantitative and semiquantitative RT-PCR analysis of GDNF and Pspn
mRNA expression during rat sciatic nerve development and in three modes of
Schwann cell differentiation. (B) Quantitative RT-PCR analysis of expression of
receptors for GDNF family members during rat sciatic nerve development and in
three modes of Schwann cell differentiation. Expression levels are represented rel-
ative to the level of the respective mRNA at E17 (in sciatic nerve development) or in38 M. Piirsoo et al. / Neuroscie
hown that Ntrk2FL is expressed at low level in adult rat sciatic
erve [8]. Here we show that, in addition to this, full-length Ntrk2
RNA is expressed in E17 embryonic nerves. Ntrk3 (TrkC), the high
fﬁnity receptor forNT-3, has twomajor isoforms, full-lengthNtrk3
arboring tyrosine kinase domain (TK+) and truncated Ntrk3 (TK−)
19]. It has been previously shown that Ntrk3 mRNA is expressed
n embryonic rat sciatic nerve from E14 to E18 [17]. Our results
howed that Ntrk3TK+ mRNA was expressed at E17 and E19 at
imilar levels, the levels increased 5-fold at P3, decreased 10-fold
t P10 and remained unchanged during later postnatal develop-
ent (Fig. 2D). Ntrk3TK− mRNA level was upregulated 5-fold at
19 as compared to E17 and gradually decreased during postnatal
evelopment (Fig. 2D). This contrasts to previously published data
howing that Ntrk3 protein level is gradually downregulated dur-
ng postnatal development of rat sciatic nerve [8], suggesting that
trk3 mRNA and protein levels are regulated in a different manner.
xpression of p75NTR mRNA, the low-afﬁnity neurotrophin recep-
or, increased 2.5-fold from E17 to E19 and was downregulated
ater during development (Fig. 2D). This is consistent with pub-
ished data showing that p75 expression is downregulated during
ostnatal development [8]. We show here for the ﬁrst time that its
xpression is even higher in embryonic sciatic nerves.
Analysis of expression of neurotrophin receptors in cultured
chwann cells showed that in differentiated cells Ntrk1mRNA level
as 17 times higher than in proliferating cells and 34 times higher
han in growth-arrested cells and 2 times lower than in adult rat
rain (Fig. 2D). Full-length Ntrk2 and Ntrk2T2 were not expressed
n cultured Schwann cells (data not shown). Ntrk2T1, Ntrk3TK+
nd Ntrk3TK− mRNA was detected in proliferating and in differ-
ntiated Schwann cells, but not in growth-arrested cells. Ntrk2T1
RNA was expressed in proliferating and differentiated Schwann
ells at similar level that was 14 times lower than in adult rat brain
Fig. 2D). Expression of Ntrk3Tk+ mRNA was induced 2-fold in dif-
erentiated cells as compared to proliferating cells and the level
as 3.5 times lower than in rat brain. Expression level of Ntrk3TK−
as similar in proliferating and differentiated Schwann cells and
n adult rat brain. Expression of p75NTR mRNA was induced 3.5-
nd 3-fold in growth-arrested and differentiated Schwann cells
espectively as compared to proliferating cells where the levels
ere still more than 300 times higher than in adult rat brain
Fig. 2D).
.2. Expression of GDNF family of neurotrophic factors and their
eceptors during rat peripheral nerve development and in
ultured Schwann cells
Next we analyzed GDNF, Artn, Pspn and Nrtn gene expres-
ion during rat sciatic nerve development (Fig. 3A). GDNF mRNA
evel was highest at E17, decreased more than 30-fold at E19
nd remained almost undetectable later during development. It
as been previously shown that GDNF is expressed in the distal
art of the lesioned adult rat sciatic nerve and in embryonic chick
ciatic nerves [27,9]. Here we show that expression of GDNF is rel-
tively high in rat embryonic sciatic nerve and is downregulated
pon nerve maturation. Pspn is expressed in two forms in mam-
als. Majority of the Pspn mRNA has intron retention, leading to
rame-shift in the open reading frame and the minor form encodes
iologically active protein [20]. Expression of the shorter functional
spn mRNA was high at E17 and E19 and decreased postnatally to
ndetectable levels. As shown previously, Pspn mRNA with intron
etention had higher expression level than the spliced mRNA and
as detected at all stages during sciatic nerve development, with
ighest levels at E17 and E19 (Fig. 3A). We did not detect Nrtn and
rtn mRNA expression in sciatic nerve (data not shown).
Analysis of GDNF expression in cultured Schwann cells showed
hat in growth-arrested cells the levels were 2-fold higher than
pSC (in Schwann cells), which was arbitrarily set at one. pSC: proliferating Schwann
cells, gaSC: growth-arrested Schwann cells, dSC: differentiated Schwann cells, BR:
adult rat brain.
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n proliferating cells, and 4-fold higher than in differentiated cells
Fig. 3A). Spliced Pspn mRNA was expressed at similar level in all
hree modes of cultured Schwann cells (Fig. 3A). Nrtn and Artn
xpression was not detected in cultured Schwann cells (data not
hown).
Next, qPCR analysis was performed to investigate expression of
eceptors for GDNF family of neurotrophic factors (Fig. 3B). It has
reviously been shown thatGfra1 is expressed in adult sciatic nerve
nd its expression is upregulated in the distal part of lesion after
erve injury [27]. Allmembers of GFR alpha receptor family, except
fra4, were expressed in rat sciatic nerve and in cultured Schwann
ells (Fig. 3B). The levels of Gfra1mRNA increased slightly fromE17
o E19, were not changed at P3 and decreased during later devel-
pment. In cultured Schwann cells Gfra1 mRNA was induced 3-
nd 2-fold in growth-arrested and in differentiated cells respec-
ively as compared to proliferating cells, where the levels were
ore than 12 times higher than in adult rat brain. Gfra2mRNA level
ecreased 4-fold at E19 as compared to E17, thereafter the levels
ncreased 10-fold up to P20 and were decreased again in adult sci-
ticnerve.Gfra3mRNA levelwas induced6-foldatE19as compared
o E17, decreased 6-fold at P3 and remained relatively unchanged
hereafter. In cultured Schwann cells Gfra3 mRNA level decreased
ore than 2-fold in growth-arrested and differentiated cells com-
ared to proliferating cells where it was more than 70 times higher
han in adult rat brain. Using in situ hybridization it has previously
een shown that Gfra3 mRNA is expressed at similar level in sciatic
erve during embryonic development [28]. In contrast, our results
howedGfra3mRNA levels increase6-fold fromE17 toE19 (Fig. 3B).
n accordance with previously published data we detected no Ret
RNA expression in cultured Schwann cells [27]. However, in the
eveloping sciatic nerve Ret mRNA was expressed, the levels were
ighest atE17,decreased10-foldatE19, remained relatively similar
p to P3 and increased thereafter (Fig. 3B). It has been shown that
DNF family of neurotrophic factors can also signal through neural
ell adhesion molecule NCAM [25]. Therefore, we analyzed NCAM
xpression in sciatic nerve and in Schwann cells (Fig. 3B). NCAM
RNA was expressed at similar level at E17 and E19, thereafter the
evels increasedgraduallyup toP20. In theadult sciaticnerveNCAM
RNA levels were decreased to 2-fold lower levels than at E17. In
ultured Schwann cells, NCAMmRNAexpression levelswere 3-fold
igher in proliferating Schwann cells than in growth-arrested and
ifferentiated cells.
Taken together, our results show that all neurotrophins, except
T-4, are expressed during rat sciatic nerve development and the
evels decrease starting from E17, the ﬁrst developmental stage
nalyzed. Cultured Schwann cells express NGF and BDNF, but
ot NT-3 and NT-4. BDNF expression is dramatically induced in
rowth-arrested Schwann cells, while NGF levels do not change
igniﬁcantly in the analyzed three modes of cell culture. All recep-
ors for neurotrophins are expressed in rat sciatic nerve. Cultured
chwann cells express all receptors for neurotrophins except full-
engthNtrk2. TwomembersofGDNF familyofneurotrophic factors,
DNF and persephin, are expressed in rat sciatic nerve and in cul-
ured Schwann cells. All Gfra receptors, except Gfra4, are expressed
n cultured Schwann cells and in sciatic nerve. Ret and NCAM core-
eptors are expressed in sciatic nerve, but only NCAM is expressed
n cultured Schwann cells.
cknowledgements
We thank Epp Väli for excellent technical assistance and Dr.
ies Meijer for providing neuregulin-beta conditioned media. This
ork was supported by the following grants to TT: Wellcome Trust
nternational Senior Research Fellowship (Grant 067952), Estonian
inistry of Education and Research (Grant 0140143), and Estonian
cience Foundation (Grant 7257).
[tters 469 (2010) 135–140 139
Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at doi:10.1016/j.neulet.2009.11.060.
References
[1] T. Aid, A. Kazantseva, M. Piirsoo, K. Palm, T. Timmusk, Mouse and rat
BDNF gene structure and expression revisited, J. Neurosci. Res. 85 (2007)
525–535.
[2] M.S. Airaksinen, M. Saarma, The GDNF family: signalling, biological functions
and therapeutic value, Nat. Rev. Neurosci. 3 (2002) 383–394.
[3] M. Bibel, Y.A. Barde, Neurotrophins: key regulators of cell fate and
cell shape in the vertebrate nervous system, Genes Dev. 14 (2000)
2919–2937.
[4] A.L. Bookout, D.J. Mangelsdorf, Quantitative real-time PCR protocol for analysis
of nuclear receptor signaling pathways, Nucl. Recept. Signal. 1 (2003) e012.
[5] J.P. Brockes, K.L. Fields,M.C. Raff, Studies on cultured rat Schwann cells. I. Estab-
lishment of puriﬁed populations from cultures of peripheral nerve, Brain Res.
165 (1979) 105–118.
[6] J.R. Chan, J.M. Cosgaya, Y.J. Wu, E.M. Shooter, Neurotrophins are key mediators
of the myelination program in the peripheral nervous system, Proc. Natl. Acad.
Sci. U.S.A. 98 (2001) 14661–14668.
[7] J.R. Chan, T.A. Watkins, J.M. Cosgaya, C. Zhang, L. Chen, L.F. Reichardt, E.M.
Shooter, B.A. Barres, NGF controls axonal receptivity to myelination by
Schwann cells or oligodendrocytes, Neuron 43 (2004) 183–191.
[8] J.M. Cosgaya, J.R. Chan, E.M. Shooter, The neurotrophin receptor p75NTR as a
positive modulator of myelination, Science 298 (2002) 1245–1248.
[9] R.M. Esper, J.A. Loeb, Rapid axoglial signaling mediated by neuregulin and neu-
rotrophic factors, J. Neurosci. 24 (2004) 6218–6227.
10] J. Frisén, V.M. Verge, K. Fried,M. Risling, H. Persson, J. Trotter, T. Hökfelt, D. Lind-
holm, Characterization of glial trkB receptors: differential response to injury
in the central and peripheral nervous systems, Proc. Natl. Acad. Sci. U.S.A. 90
(1993) 4971–4975.
11] H. Funakoshi, J. Frisén, G. Barbany, T. Timmusk, O. Zachrisson, V.M. Verge, H.
Persson, Differential expression of mRNAs for neurotrophins and their recep-
tors after axotomy of the sciatic nerve, J. Cell Biol. 123 (1993) 455–465.
12] A. Höke, T. Ho, T.O. Crawford, C. LeBel, D. Hilt, J.W. Grifﬁn, Glial cell line-derived
neurotrophic factor alters axon Schwann cell units and promotes myelination
in unmyelinated nerve ﬁbers, J. Neurosci. 23 (2003) 561–567.
13] A. Höke, R. Redett, H. Hameed, R. Jari, C. Zhou, Z.B. Li, J.W. Grifﬁn, T.M. Brushart,
Schwanncells expressmotorandsensoryphenotypes that regulateaxonregen-
eration, J. Neurosci. 26 (2006) 9646–9655.
14] T. Iwase, C.G. Jung, H. Bae, M. Zhang, B. Soliven, Glial cell line-derived neu-
rotrophic factor-induced signaling in Schwann cells, J. Neurochem. 94 (2005)
1488–1499.
15] K.R. Jessen, R. Mirsky, The origin and development of glial cells in peripheral
nerves, Nat. Rev. Neurosci. 6 (2005) 671–682.
16] R. Klein, D. Conway, L.F. Parada, M. Barbacid, The trkB tyrosine protein kinase
gene codes for a second neurogenic receptor that lacks the catalytic kinase
domain, Cell 61 (1990) 647–656.
17] C.S. Lobsiger, B. Schweitzer, V. Taylor, U. Suter, Platelet-derived growth factor-
BB supports the survival of cultured rat Schwann cell precursors in synergy
with neurotrophin-3, Glia 30 (2000) 290–300.
18] M. Meyer, I. Matsuoka, C. Wetmore, L. Olson, H. Thoenen, Enhanced synthesis
of brain-derived neurotrophic factor in the lesioned peripheral nerve: different
mechanisms are responsible for the regulation of BDNF and NGF mRNA, J. Cell
Biol. 119 (1992) 45–54.
19] D.S. Middlemas, R.A. Lindberg, T. Hunter, trkB, a neural receptor protein-
tyrosine kinase: evidence for a full-length and two truncated receptors, Mol.
Cell. Biol. 11 (1991) 143–153.
20] J. Milbrandt, F.J. de Sauvage, T.J. Fahrner, R.H. Baloh, M.L. Leitner, M.G. Tansey,
P.A. Lampe, R.O. Heuckeroth, P.T. Kotzbauer, K.S. Simburger, J.P. Golden, J.A.
Davies, R. Vejsada, A.C. Kato, M. Hynes, D. Sherman, M. Nishimura, L.C. Wang,
R. Vandlen, B. Moffat, R.D. Klein, K. Poulsen, C. Gray, A. Garces, C.E. Henderson,
H.S. Phillips, E.M. Johnson Jr., Persephin, a novel neurotrophic factor related to
GDNF and neurturin, Neuron 20 (1998) 245–253.
21] P.V. Monje, S. Rendon, G. Athauda, M. Bates, P.M. Wood, M.B. Bunge, Non-
antagonistic relationship between mitogenic factors and cAMP in adult
Schwann cell re-differentiation, Glia 57 (2009) 947–961.
22] B.K. Ng, L. Chen, W. Mandemakers, J.M. Cosgaya, J.R. Chan, Anterograde trans-
port and secretion of brain-derived neurotrophic factor along sensory axons
promote Schwann cell myelination, J. Neurosci. 27 (2007) 7597–7603.
23] N. Offenhäuser, R. Böhm-Matthaei, P. Tsoulfas, L. Parada, M. Meyer, Develop-
mental regulation of full-length trkC in the rat sciatic nerve, Eur. J. Neurosci. 7
(1995) 917–925.
24] T. Päll, A. Gad, L. Kasak, M. Drews, S. Strömblad, P. Kogerman, Recombinant
CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing
endothelial cell-speciﬁc growth inhibition independently of hyaluronic acid
binding, Oncogene 23 (2004) 7874–7881.
25] G. Paratcha, F. Ledda, C.F. Ibán˜ez, The neural cell adhesion molecule NCAM
is an alternative signaling receptor for GDNF family ligands, Cell 113 (2003)
867–879.
1 nce Le
[
[
[40 M. Piirsoo et al. / Neuroscie
26] R.J. Tolwani, J.M. Cosgaya, S. Varma, R. Jacob, L.E. Kuo, E.M. Shooter, BDNF over-
expressionproduces a long-term increase inmyelin formation in theperipheral
nervous system, J. Neurosci. Res. 77 (2004) 662–669.
27] M. Trupp,M. Rydén,H. Jörnvall, H. Funakoshi, T. Timmusk, E. Arenas, C.F. Ibán˜ez,
Peripheral expression and biological activities of GDNF, a new neurotrophic
factor for avian and mammalian peripheral neurons, J. Cell Biol. 130 (1995)
137–148.
[tters 469 (2010) 135–140
28] J. Widenfalk, A. Tomac, E. Lindqvist, B. Hoffer, L. Olson, GFRalpha-3,
a protein related to GFRalpha-1, is expressed in developing periph-
eral neurons and ensheathing cells, Eur. J. Neurosci. 10 (1998) 1508–
1517.
29] J.Y. Zhang, X.G. Luo, C.J. Xian, Z.H. Liu, X.F. Zhou, Endogenous BDNF is required
for myelination and regeneration of injured sciatic nerve in rodents, Eur. J.
Neurosci. 12 (2000) 4171–4180.
